Back

Effects of empagliflozin on myocardial transcriptome in rats with aortic stenosis-induced heart failure

30 August 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: New molecular insights into valvular heart disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Marina Okoshi

Faculty of Medicine of Botucatu, UNESP, Botucatu (Brazil)

8 More presentations in this session

Presentation thumbnail
Nitisinone attenuates progression of aortic stenosis in patients with alkaptonuria: an analysis of the SONIA 2 study
Doctor C. Bruce (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Aortic valve stenosis augments long noncoding RNA H19 to govern angiogenic responses and phenotypes of valvular endothelial cell through endothelial to mesenchymal transition
Doctor M. Hosen (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk
Doctor M. Hosen (Bonn, DE)
Abstract Slides
Presentation thumbnail
Impact of plasma from patients with severe aortic stenosis on valvular endothelial cells
Doctor A. Trimaille (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Paired single-cell RNA sequencing and T cell receptor sequencing reveals both pro- and anti-inflammatory roles of T cells in patients with calcific aortic valve disease
Miss X. Zhang (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
New molecular insights into valvular heart disease

The Event

Event poster

ESC Congress 2024

30 August 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of SGLT2 inhibition on cardiac remodeling and heart failure development in rats with aortic stenosis
thumbnail
Congress Presentation
Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity.
thumbnail
Congress Presentation
Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources